Peter Nigrovic

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    BMS
    Topic:
    arthritis
    Date added:
    11/16/2021
    Date updated:
    11/16/2021
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    BMS
    Topic:
    arthritis
    Date added:
    11/16/2021
    Date updated:
    11/16/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Miach Orthopaedics
    Topic:
    DSMB chair
    Date added:
    11/16/2021
    Date updated:
    11/16/2021
    Relationship end date:
    11/10/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Cerecor
    Topic:
    arthritis
    Date added:
    11/16/2021
    Date updated:
    11/16/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Pfizer
    Topic:
    arthritis
    Date added:
    11/16/2021
    Date updated:
    11/16/2021
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Pfizer
    Topic:
    neutrophil biology
    Date added:
    11/16/2021
    Date updated:
    11/16/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Quench Bio
    Topic:
    inflammasome
    Date added:
    11/16/2021
    Date updated:
    11/16/2021
    Relationship end date:
    06/01/2020
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Sigilon
    Topic:
    inflammation
    Date added:
    11/16/2021
    Date updated:
    11/16/2021
    Relationship end date:
    05/01/2020
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Exo Therapeutics
    Topic:
    inflammation
    Date added:
    11/16/2021
    Date updated:
    11/16/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Novartis
    Topic:
    arthritis
    Date added:
    11/16/2021
    Date updated:
    11/16/2021

Pages

Return to 152 Pediatric Grand Rounds: Update on Juvenile Idiopathic Arthritis” (121521)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.